Immunogenicity of ChAdOx1 nCoV-19 Booster Vaccination Following Two CoronaVac Shots in Healthcare Workers

During the early phase of the COVID-19 pandemic, several countries, including Thailand, provided two shots of CoronaVac to healthcare workers. Whereas ChAdOx1 nCoV-19 is the promising vaccine as the booster dose, the data on immunogenicity when administered after CoronaVac have been limited. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasithsirikul, Wisit, Pongpirul, Krit, Nopsopon, Tanawin, Phutrakool, Phanupong, Pongpirul, Wannarat, Samuthpongtorn, Chatpol, Suwanwattana, Pawita, Jongkaewwattana, Anan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878194/
https://www.ncbi.nlm.nih.gov/pubmed/35214675
http://dx.doi.org/10.3390/vaccines10020217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878194/
https://www.ncbi.nlm.nih.gov/pubmed/35214675
http://dx.doi.org/10.3390/vaccines10020217

Ejemplares similares